Cargando…
Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk
(1) Background: The relationship between anxiety and depression in metabolic-dysfunction-associated fatty liver disease (MAFLD) and cardiovascular (CV) risk remains uncertain. Therefore, we aimed to assess whether anxiety and depression are associated with increased CV risk in MAFLD. (2) Methods: We...
Autores principales: | Ismaiel, Abdulrahman, Spinu, Mihail, Leucuta, Daniel-Corneliu, Popa, Stefan-Lucian, Chis, Bogdan Augustin, Fadgyas Stanculete, Mihaela, Olinic, Dan Mircea, Dumitrascu, Dan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102968/ https://www.ncbi.nlm.nih.gov/pubmed/35566616 http://dx.doi.org/10.3390/jcm11092488 |
Ejemplares similares
-
Relationship between Adipokines and Cardiovascular Ultrasound Parameters in Metabolic-Dysfunction-Associated Fatty Liver Disease
por: Ismaiel, Abdulrahman, et al.
Publicado: (2021) -
MBOAT7 rs641738 variant in metabolic-dysfunction-associated fatty liver disease and cardiovascular risk
por: Ismaiel, Abdulrahman, et al.
Publicado: (2023) -
Metabolic biomarkers related to cardiac dysfunction in metabolic-dysfunction-associated fatty liver disease: a cross-sectional analysis
por: Ismaiel, Abdulrahman, et al.
Publicado: (2022) -
Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
por: Ismaiel, Abdulrahman, et al.
Publicado: (2021) -
The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis
por: Ismaiel, Abdulrahman, et al.
Publicado: (2021)